Results 251 to 260 of about 355,585 (385)

Laboratory Assessment of the Anticoagulant Activity of Direct Oral Anticoagulants: A Systematic Review

Chest, 2017
B. Samuelson, A. Cuker, D. Siegal, M. Crowther, D. Garcia   +4 more
semanticscholar   +1 more source

Incidence and Predictors of Hypoattenuated Thickening and Device‐Related Thrombus at Three Months Postprocedural CT Assessment Following Left Atrial Appendage Occlusion With Amplatzer Devices—A Single‐Center Cohort

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Left atrial appendage occlusion (LAAO) has become a valuable alternative to long‐term anticoagulation for stroke prevention in patients with non‐valvular atrial fibrillation (AF), especially in those at high bleeding risk. Hypoattenuated thickening (HAT) and device‐related thrombus (DRT) remain notable postprocedural concerns ...
Pierre Guilleminot, Carole Richard, Antoine Roger, Marlène Daller, Gabriel Laurent, Catherine Vergely, Charles Guenancia, Thibaut Pommier   +7 more
wiley   +1 more source

Hemorrhagic Events Associated With Direct Oral Anticoagulants: Frequency and Management. [PDF]

Cureus
Ztati M, Zaanouny O, Nasim A, El Hattaoui M.   +3 more
europepmc   +1 more source

Antithrombotic treatment with direct‐acting oral anticoagulants in patients with splanchnic vein thrombosis and cirrhosis

Liver international (Print), 2017
A. de Gottardi, J. Trebicka, C. Klinger, A. Plessier, S. Seijo, B. Terziroli, L. Magenta, D. Semela, E. Buscarini, P. Langlet, J. Görtzen, A. Puente, B. Müllhaupt, C. Navascués, F. Nery, P. Deltenre, F. Turon, C. Engelmann, R. Arya, K. Caca, M. Peck‐Radosavljevic, F. Leebeek, D. Valla, J. García‐Pagán   +23 more
semanticscholar   +1 more source

Harnessing Algal Biorefineries for Waste to Wealth Paradigm: A Pathway Toward Circular and Sustainable Bioeconomy

CleanMat, EarlyView.
This review highlights the use of wastewater from various sources including industrial, municipal, and agricultural effluents for microalgal cultivation. It emphasizes on the integrated approach of wastewater treatment and microalgal biomass production for high value‐added bioproducts such as biofuels, animal feed, biofertilizers, bioplastics while ...
Prachi Bhatnagar, Sonia Choudhary, Anwesha Dey, Krishna Mohan Poluri   +3 more
wiley   +1 more source

Concomitant anticoagulants and the survival of cancer patients treated with immune checkpoint inhibitors: a meta-analysis. [PDF]

Sci Rep
Xiong J, Jian H, Yang Z, Xia L.
europepmc   +1 more source

Clinical Pharmacology of Oral Anticoagulants in Patients with Kidney Disease.

American Society of Nephrology. Clinical Journal, 2019
N. Jain, R. Reilly
semanticscholar   +1 more source

Relative Bioavailability, Food Effect, and Bioequivalence Studies to Assess a New Zanubrutinib 160‐mg Tablet: Results From 2 Phase 1 Studies in Healthy Volunteers

Clinical Pharmacology in Drug Development, EarlyView.
Abstract Zanubrutinib is a next‐generation Bruton tyrosine kinase inhibitor approved for treating B‐cell malignancies. Two phase 1 studies evaluated a new 160‐mg zanubrutinib tablet versus 80‐mg capsules. In study BGB‐3111‐115 (n = 43), a randomized 3‐period crossover trial, relative bioavailability and food effects were assessed.
Bilal Tariq, Chester Lin, Vaibhav Mundra, Yang Gao, Dan Zhang, Ying C. Ou   +5 more
wiley   +1 more source

Hemorrhage Risk Associated with Anticoagulant and Antiplatelet Drug Combinations: Insights from the USFDA Adverse Event Reporting System. [PDF]

J Clin Med
Sridharan K, Sivaramakrishnan G.
europepmc   +1 more source

New Anticoagulants [PDF]

Circulation, 2010
John W, Eikelboom, Jeffrey I, Weitz
openaire   +2 more sources